Particle.news

Download on the App Store

DeepMind Launches AlphaGenome to Map Non-Coding DNA Regulation

The model is available via API for non-commercial research to accelerate studies of genetic disease by predicting regulatory impacts of DNA variants.

Image
Image
April 2, 2024, Brazil. In this photo illustration, the Google DeepMind logo is displayed on a smartphone screen
Image

Overview

  • AlphaGenome analyzes sequences of up to one million DNA base pairs in a single pass, delivering base-level predictions for gene expression, splicing patterns, protein binding and chromatin accessibility across diverse cell types.
  • In 24 out of 26 benchmark tests the model matched or outperformed specialized AI tools for predicting gene regulation and variant effects.
  • DeepMind trained AlphaGenome on large public datasets including ENCODE, GTEx, 4D Nucleome and FANTOM5 using a U-Net-inspired neural architecture with about 450 million parameters.
  • Using Google’s custom Tensor Processing Units, the team completed pre-training and distillation in just four hours while halving the computational cost compared with its predecessor.
  • Researchers are already applying the preview API to study non-coding mutations in cancer and rare genetic disorders, with plans for a broader open-source release to expand accessibility.